The function(s) and RNA binding properties of vigilin, a ubiquitous protein with 14 KH domains, remain largely obscure. We recently showed that vigilin is the estrogen-inducible protein in polysome extracts which binds specifically to a segment of the 3 untranslated region (UTR) of estrogen-stabilized vitellogenin mRNA. In order to identify consensus mRNA sequences and structures important in binding of vigilin to RNA, before vigilin was purified, we developed a modified in vitro genetic selection protocol. We subsequently validated our selection procedure, which employed crude polysome extracts, by testing natural and in vitro-selected RNAs with purified recombinant vigilin. Most of the selected up-binding mutants exhibited hypermutation of G residues leading to a largely unstructured, single-stranded region containing multiple conserved (A) n CU and UC(A) n motifs. All eight of the selected down-binding mutants contained a mutation in the sequence (A) n CU. Deletion analysis indicated that approximately 75 nucleotides are required for maximal binding. Using this information, we predicted and subsequently identified a strong vigilin binding site near the 3 end of human dystrophin mRNA. RNA sequences from the 3 UTRs of transferrin receptor and estrogen receptor, which lack strong homology to the selected sequences, did not bind vigilin. These studies describe an aproach to identifying long RNA binding sites and describe sequence and structural requirements for interaction of vigilin with RNAs.The steps between gene transcription and mRNA translation, which include nuclear RNA processing, mRNA trafficking, and cytoplasmic mRNA degradation, are increasingly seen as important regulatory sites in diverse cellular processes (5, 6, 52). Many of these steps in mRNA metabolism appear to be regulated by RNA binding proteins containing K-homology (KH) domains (14). While a detailed picture of KH-domain-RNA interaction is not yet available, in several cases proteins containing KH domains have been shown to bind RNA (13,14,21,57). Some KH-domain proteins are clinically significant, including FMR1 protein (57), which is involved in fragile X syndrome, the major cause of heritable human mental retardation, and Nova-1, which is important in the motor control disorder paraneoplastic opsoclonus-ataxia (12, 13). KH-domain proteins which affect nuclear RNA splicing include Mer1, SF1, and PSI (1, 46, 55), while the ␣-poly(C) binding protein plays a role in the cytoplasmic stability of globin mRNA (68). Prokaryotic KH-domain proteins are highly diverse and include NusA, polyribonucleotide:orthophosphate nucleotidyltransferase, CsrA, and ribosomal protein S3 (27,40,58). Since the RNA binding sites and mechanisms of action of many KH-domain proteins remain obscure, the question of whether KH-domain proteins can preferentially recognize and bind to specific RNA binding sites remained unresolved. In an important recent paper, Buckanovich and Darnell used in vitro genetic selection with purified recombinant Nova-1 to identify RNAs which ...